Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?


Autoria(s): Lewis, Gareth; Maxwell, Alexander P
Data(s)

01/05/2014

Identificador

http://pure.qub.ac.uk/portal/en/publications/should-women-with-diabetic-nephropathy-considering-pregnancy-continue-ace-inhibitor-or-angiotensin-ii-receptor-blocker-therapy-until-pregnancy-is-confirmed(2b5a82d6-2b65-446c-b72a-435577d11c6e).html

http://dx.doi.org/10.1007/s00125-014-3188-x

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Lewis , G & Maxwell , A P 2014 , ' Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? ' Diabetologia , vol 57 , no. 5 , pp. 1082-1083 . DOI: 10.1007/s00125-014-3188-x

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2724 #Internal Medicine #/dk/atira/pure/subjectarea/asjc/2700/2712 #Endocrinology, Diabetes and Metabolism
Tipo

article